Free Trial

Bright Minds Biosciences (DRUG) Competitors

Bright Minds Biosciences logo
$26.58 -0.16 (-0.60%)
Closing price 07/9/2025 04:00 PM Eastern
Extended Trading
$26.56 -0.02 (-0.08%)
As of 05:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DRUG vs. GHRS, STOK, SANA, MRVI, URGN, AUTL, CDXC, CDTX, ABUS, and EOLS

Should you be buying Bright Minds Biosciences stock or one of its competitors? The main competitors of Bright Minds Biosciences include GH Research (GHRS), Stoke Therapeutics (STOK), Sana Biotechnology (SANA), Maravai LifeSciences (MRVI), Urogen Pharma (URGN), Autolus Therapeutics (AUTL), ChromaDex (CDXC), Cidara Therapeutics (CDTX), Arbutus Biopharma (ABUS), and Evolus (EOLS). These companies are all part of the "pharmaceutical products" industry.

Bright Minds Biosciences vs. Its Competitors

GH Research (NASDAQ:GHRS) and Bright Minds Biosciences (NASDAQ:DRUG) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

GH Research has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, Bright Minds Biosciences has a beta of -6.01, suggesting that its stock price is 701% less volatile than the S&P 500.

Bright Minds Biosciences is trading at a lower price-to-earnings ratio than GH Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GH ResearchN/AN/A-$38.96M-$0.79-19.59
Bright Minds BiosciencesN/AN/A-$2.06M-$0.36-73.83

In the previous week, GH Research had 1 more articles in the media than Bright Minds Biosciences. MarketBeat recorded 7 mentions for GH Research and 6 mentions for Bright Minds Biosciences. GH Research's average media sentiment score of 0.20 beat Bright Minds Biosciences' score of 0.04 indicating that GH Research is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GH Research
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Bright Minds Biosciences
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

GH Research currently has a consensus target price of $32.00, suggesting a potential upside of 106.72%. Bright Minds Biosciences has a consensus target price of $83.25, suggesting a potential upside of 213.21%. Given Bright Minds Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Bright Minds Biosciences is more favorable than GH Research.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GH Research
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00
Bright Minds Biosciences
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13

56.9% of GH Research shares are held by institutional investors. Comparatively, 40.5% of Bright Minds Biosciences shares are held by institutional investors. 41.6% of GH Research shares are held by insiders. Comparatively, 42.7% of Bright Minds Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Bright Minds Biosciences' return on equity of -14.56% beat GH Research's return on equity.

Company Net Margins Return on Equity Return on Assets
GH ResearchN/A -19.20% -18.40%
Bright Minds Biosciences N/A -14.56%-14.29%

Summary

Bright Minds Biosciences beats GH Research on 8 of the 13 factors compared between the two stocks.

Get Bright Minds Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRUG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRUG vs. The Competition

MetricBright Minds BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$188.36M$2.90B$5.51B$8.95B
Dividend YieldN/A2.44%5.25%4.02%
P/E Ratio-73.8321.0128.0020.16
Price / SalesN/A259.24409.36175.34
Price / CashN/A41.8337.0657.97
Price / Book28.897.868.145.62
Net Income-$2.06M-$54.96M$3.16B$248.50M
7 Day Performance-6.08%5.27%3.15%4.49%
1 Month Performance-5.98%3.78%3.48%7.03%
1 Year Performance2,558.00%5.85%34.27%21.07%

Bright Minds Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRUG
Bright Minds Biosciences
2.7067 of 5 stars
$26.58
-0.6%
$83.25
+213.2%
+2,493.2%$188.36MN/A-73.83N/A
GHRS
GH Research
2.0652 of 5 stars
$12.19
-2.0%
$32.00
+162.5%
+37.0%$647.23MN/A-15.4310News Coverage
STOK
Stoke Therapeutics
3.8906 of 5 stars
$11.35
-2.4%
$23.20
+104.4%
-10.2%$634.96M$190.91M14.37100
SANA
Sana Biotechnology
2.5862 of 5 stars
$2.73
-2.8%
$8.60
+215.0%
-22.6%$633.59MN/A-3.10380Gap Up
MRVI
Maravai LifeSciences
3.7009 of 5 stars
$2.41
-2.4%
$6.64
+175.5%
-63.5%$629.01M$259.18M-2.11610Positive News
Options Volume
URGN
Urogen Pharma
4.5482 of 5 stars
$13.70
+1.6%
$32.86
+139.8%
-17.1%$621.99M$90.40M-4.31200Analyst Forecast
AUTL
Autolus Therapeutics
2.1465 of 5 stars
$2.28
-1.3%
$9.32
+308.8%
-35.0%$614.79M$10.12M-2.59330
CDXC
ChromaDex
3.1851 of 5 stars
N/A$9.03
+∞
N/A$611.50M$99.60M787.29120
CDTX
Cidara Therapeutics
4.1328 of 5 stars
$48.71
-1.5%
$57.14
+17.3%
+342.2%$603.74M$1.27M-1.6590High Trading Volume
ABUS
Arbutus Biopharma
1.4335 of 5 stars
$3.09
-1.3%
$5.50
+78.0%
-1.8%$599.48M$6.17M-7.5490
EOLS
Evolus
3.692 of 5 stars
$9.21
+0.8%
$23.75
+157.9%
-13.5%$589.31M$266.27M-10.35170News Coverage

Related Companies and Tools


This page (NASDAQ:DRUG) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners